Advertisement

Mycopathologia

, Volume 175, Issue 1–2, pp 99–106 | Cite as

Disseminated Zygomycosis Caused by Cunninghamella bertholletiae in Patient with Hematological Malignancy and Review of Published Case Reports

  • Tsung-Ting Hsieh
  • Hsiang-Kuang Tseng
  • Pei-Lun SunEmail author
  • Yu-Hung Wu
  • Gon-Shen Chen
Article

Abstract

Cunninghamella bertholletiae is an unusual opportunistic pathogen belonging to the class Zygomycetes, order Mucorales, and the family Cunninghamellaceae. It has been identified with increased frequency in immunocompromised patients, especially those with hematological malignancy. Clinical infection by this fungus is almost always devastating. We report a fatal case of disseminated zygomycosis due to Cunninghamella bertholletiae in an acute myeloid leukemia patient without chemotherapy. We also reviewed the cases of Cunninghamella bertholletiae infection reported in these 20 years. These cases highlight the high mortality rate and rapid progression associated with this opportunistic fungal infection in immunocompromised patients.

Keywords

Acute myeloid leukemia Disseminated Zygomycosis Cunninghamella bertholletiae 

References

  1. 1.
    Gomes MZR, Lewis RE, Kontoyiannis DP. Mucormycosis caused by unusual mucormycetes, non-Rhizopus, -Mucor, and -Lichtheimia species. Clin Microbiol Rev. 2011;24(2):411–45.PubMedCrossRefGoogle Scholar
  2. 2.
    De Hoog GS, Guarro J, Gene J, Figueras MJ. Atlas of clinical fungi. 2nd ed. Utrecht: Centraalbureau voor Schimmelcultures; 2000.Google Scholar
  3. 3.
    Hsieh HM, Ju YM, Hsueh PR, Lin HY, Hu FR, Chen WL. Fungal keratitis caused by a new filamentous hyphomycete Sagenomella keratitidis. Bot Stud. 2009;50:331–5.Google Scholar
  4. 4.
    Diwakar A, Dewan RK, Chowdhary A, Randhawa HS, Khanna G, Gaur SN. Zygomycosis ? A case report and overview of the disease in India. Mycoses. 2007;50(4):247–54.PubMedCrossRefGoogle Scholar
  5. 5.
    Alvarez E, Sutton DA, Cano J, Fothergill AW, Stchigel A, Rinaldi MG, et al. Spectrum of zygomycete species identified in clinically significant specimens in the United States. J Clin Microbiol. 2009;47(6):1650–6.PubMedCrossRefGoogle Scholar
  6. 6.
    Kontoyianis DP, Vartivarian S, Anaissie EJ, Samonis G, Bodey GP, Rinaldi M. Infections due to Cunninghamella bertholletiae in patients with cancer: report of three cases and review. Clin Infect Dis. 1994;18(6):925–8.PubMedCrossRefGoogle Scholar
  7. 7.
    Naumann R, Kerkmann ML, Schuler U, Daniel WG, Ehninger G. Cunninghamella bertholletiae infection mimicking myocardial infarction. Clin Infect Dis. 1999;29(6):1580–1.PubMedCrossRefGoogle Scholar
  8. 8.
    Darrisaw L, Hanson G, Vesole DH, Kehl SC. Cunninghamella infection post bone marrow transplant: case report and review of the literature. Bone Marrow Transplant. 2000;25(11):1213–6.PubMedCrossRefGoogle Scholar
  9. 9.
    Ortín X, Escoda L, Llorente A, Rodriguez R, Martínez S, Boixadera J, et al. Cunninghamella bertholletiae infection (mucormycosis) in a patient with acute T-cell lymphoblastic leukemia. Leuk Lymphoma. 2004;45(3):617–20.PubMedCrossRefGoogle Scholar
  10. 10.
    Hampson F, Ridgway E, Feeley K, Reilly J. A fatal case of disseminated zygomycosis associated with the use of blood glucose self-monitoring equipment. J Infect. 2005;51(5):e269–72.PubMedCrossRefGoogle Scholar
  11. 11.
    Mayayo E, Klock C, Goldani L. Thyroid involvement in disseminated zygomycosis by Cunninghamella bertholletiae: 2 cases and literature review. Int J Surg Pathol. 2011;19(1):75–9.PubMedGoogle Scholar
  12. 12.
    Robinson BE, Stark MT, Pope TL, Stewart FM, Donowitz GR. Cunninghamella bertholletiae: an unusual agent of zygomycosis. South Med J. 1990;83(9):1088–91.PubMedCrossRefGoogle Scholar
  13. 13.
    Cohen-Abbo A, Bozeman PM, Patrick CC. Cunninghamella infections: review and report of two cases of Cunninghamella pneumonia in immunocompromised children. Clin Infect Dis. 1993;17(2):173–7.PubMedCrossRefGoogle Scholar
  14. 14.
    Ng TT, Campbell CK, Rothera M, Houghton JB, Hughes D, Denning DW. Successful treatment of sinusitis caused by Cunninghamella bertholletiae. Clin Infect Dis. 1994;19(2):313–6.PubMedCrossRefGoogle Scholar
  15. 15.
    Mazade MA, Margolin JF, Rossmann SN, Edwards MS. Survival from pulmonary infection with Cunninghamella bertholletiae: case report and review of the literature. Pediatr Infect Dis J. 1998;17(9):835–9.PubMedCrossRefGoogle Scholar
  16. 16.
    Rickerts V, Bohme A, Viertel A, Behrendt G, Jacobi V, Tintelnot K, et al. Cluster of pulmonary infections caused by Cunninghamella bertholletiae in immunocompromised patients. Clin Infect Dis. 2000;31(4):910–3.PubMedCrossRefGoogle Scholar
  17. 17.
    Garey KW, Pendland SL, Huynh VT, Bunch TH, Jensen GM, Pursell KJ. Cunninghamella bertholletiae infection in a bone marrow transplant patient: amphotericin lung penetration, MIC determinations, and review of the literature. Pharmacotherapy. 2001;21(7):855–60.PubMedCrossRefGoogle Scholar
  18. 18.
    Sivakumar S, Mathews MS, George B. Cunninghamella pneumonia in postbone marrow transplant patient: first case report from India. Mycoses. 2005;48(5):360–2.PubMedCrossRefGoogle Scholar
  19. 19.
    Paul S, Marty FM, Colson YL. Treatment of cavitary pulmonary zygomycosis with surgical resection and posaconazole. Ann Thorac Surg. 2006;82(1):338–40.PubMedCrossRefGoogle Scholar
  20. 20.
    Bibashi E, Sidi V, Kotsiou M, Makrigiannaki E, Koliouskas D. Pulmonary zygomycosis caused by Cunninghamella bertholletiae in a child with acute lymphoblastic leukemia. Hippokratia. 2008;12(1):43–5.PubMedGoogle Scholar
  21. 21.
    Righi E, Giacomazzi CG, Lindstrom V, Albarello A, Soro O, Miglino M, et al. A case of Cunninghamella bertholettiae rhino-cerebral infection in a leukaemic patient and review of recent published studies. Mycopathologia. 2008;165(6):407–10.PubMedCrossRefGoogle Scholar
  22. 22.
    Yagi S-I, Miyashita N, Fukuda M, Obase Y, Yoshida K, Miyauchi A, et al. Pulmonary mucormycosis (Cunninghamella bertholletiae) with cavitation diagnosed using ultra-thin fibre-optic bronchoscopy. Respirology. 2008;13(2):312–4.PubMedCrossRefGoogle Scholar
  23. 23.
    Motohashi K, Ito S, Hagihara M, Maruta A, Ishigatsubo Y, Kanamori H. Cutaneous zygomycosis caused byCunninghamella bertholletiae in a patient with chronic myelogenous leukemia in blast crisis. Am J Hematol. 2009;84(7):447–8.PubMedCrossRefGoogle Scholar
  24. 24.
    Garbino J, Myers C, Ambrosioni J, Gumy-Pause F. Report of a successful treatment of pulmonary Cunninghamella bertholletiae infection with liposomal amphotericin and posaconazole in a child with GvHD and review of the literature. J Pediatr Hematol Oncol. 2010;32(2):85–7.PubMedCrossRefGoogle Scholar
  25. 25.
    Maloisel F, Dufour P, Waller J, Herbrecht R, Marcellin L, Koenig H, et al. Cunninghamella bertholletiae: an uncommon agent of opportunistic fungal infection. Case report and review. Nouv Rev Fr Hematol. 1991;33(4):311–5.PubMedGoogle Scholar
  26. 26.
    Zhang R, Zhang JW, Szerlip HM. Endocarditis and hemorrhagic stroke caused by Cunninghamella bertholletiae infection after kidney transplantation. Am J Kidney Dis. 2002;40(4):842–6.PubMedCrossRefGoogle Scholar
  27. 27.
    Mehta N. Native aortic valve vegetative endocarditis with Cunninghamella. Eur J Echocardiogr. 2004;5(2):156–8.PubMedCrossRefGoogle Scholar
  28. 28.
    Passos XS, Sales WS, Maciel PJ, Costa CR, Ferreira DM, Silva MRR. Nosocomial invasive infection caused by Cunninghamella bertholletiae: case report. Mycopathologia. 2006;161(1):33–5.PubMedCrossRefGoogle Scholar
  29. 29.
    Zeilender S, Drenning D, Glauser FL, Bechard D. Fatal Cunninghamella bertholletiae infection in an immunocompetent patient. Chest. 1990;97(6):1482–3.PubMedCrossRefGoogle Scholar
  30. 30.
    Chetchotisakd P, Boonma P, Sookpranee M, Pairojkul C. Rhinocerebral mucormycosis: a report of eleven cases. Southeast Asian J Trop Med Public Health. 1991;22(2):268–73.PubMedGoogle Scholar
  31. 31.
    Sato M, Gemma H, Sano T, Ono T, Atsumi E, Ito I, et al. Pulmonary mucormycosis caused by Cunninghamella bertholletiae in a non-immunocompromised woman. Nihon Kokyuki Gakkai Zasshi. 2001;39(10):758–62.PubMedGoogle Scholar
  32. 32.
    Quinio D, Karam A, Leroy JP, Moal MC, Bourbigot B, Masure O, et al. Zygomycosis caused by Cunninghamella bertholletiae in a kidney transplant recipient. Med Mycol. 2004;42(2):177–80.PubMedCrossRefGoogle Scholar
  33. 33.
    Jayasuriya NSS, Tilakaratne WM, Amaratunga E, Ekanayake MKB. An unusual presentation of rhinofacial zygomycosis due to Cunninghamella sp. in an immunocompetent patient: a case report and literature review. Oral Dis. 2006;12(1):67–9.PubMedCrossRefGoogle Scholar
  34. 34.
    Koyama N, Nagata M, Hagiwara K, Kanazawa M. Survival of a patient with pulmonary Cunninghamella bertholletiae infection without surgical intervention. Respirology. 2008;13(2):309–11.PubMedCrossRefGoogle Scholar
  35. 35.
    Ashkenazi-Hoffnung L, Bilavsky E, Avitzur Y, Amir J. Successful treatment of cutaneous zygomycosis with intravenous amphotericin B followed by oral posaconazole in a multivisceral transplant recipient. Transplantation. 2010;90(10):1133–5.PubMedCrossRefGoogle Scholar
  36. 36.
    Mukasa Y, Ichiyasu H, Akaike K, Okamoto S, Komohara Y, Kohrogi H. Autopsy case of pulmonary zygomycosis and pneumocystis pneumonia in a patient with interstitial pneumonia treated by corticosteroid therapy. Nihon Kokyuki Gakkai Zasshi. 2010;48(11):847–54.PubMedGoogle Scholar
  37. 37.
    Pimentel JD. Peritonitis due to Cunninghamella bertholletiae in a patient undergoing continuous ambulatory peritoneal dialysis. J Med Microbiol. 2006;55(1):115–8.PubMedCrossRefGoogle Scholar
  38. 38.
    Cornely OA. Current controversies in treating invasive zygomycosis. J Pediatr Hematol Oncol. 2010;32(2):83–4.PubMedCrossRefGoogle Scholar
  39. 39.
    Trifilio S, Singhal S, Williams S, Frankfurt O, Gordon L, Evens A, et al. Breakthrough fungal infections after allogeneic hematopoietic stem cell transplantation in patients on prophylactic voriconazole. Bone Marrow Transplant. 2007;40(5):451–6.PubMedCrossRefGoogle Scholar
  40. 40.
    Almyroudis NG, Sutton DA, Fothergill AW, Rinaldi MG, Kusne S. In vitro susceptibilities of 217 clinical isolates of zygomycetes to conventional and new antifungal agents. Antimicrob Agents Chemother. 2007;51(7):2587–90.PubMedCrossRefGoogle Scholar
  41. 41.
    Roden MM, Zaoutis TE, Buchanan WL, Knudsen TA, Sarkisova TA, Schaufele RL, et al. Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis. 2005;41(5):634–53.PubMedCrossRefGoogle Scholar
  42. 42.
    Fronek J, Hearfield H, Fassiadis N, Magrill D, Morsy M, Kessaris N. Inferior epigastric vein as an interposition graft for renal transplant artery reconstruction. Transplantation. 2010;90(10):1132–3.PubMedCrossRefGoogle Scholar
  43. 43.
    Perkhofer S, Locher M, Cuenca-Estrella M, Ruchel R, Wurzner R, Dierich MP, et al. Posaconazole enhances the activity of amphotericin B against hyphae of zygomycetes in vitro. Antimicrob Agents Chemother. 2008;52(7):2636–8.PubMedCrossRefGoogle Scholar
  44. 44.
    Rogers TR. Treatment of zygomycosis: current and new options. J Antimicrob Chemother. 2008;61(Supplement 1):i35–40.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media Dordrecht 2012

Authors and Affiliations

  • Tsung-Ting Hsieh
    • 1
  • Hsiang-Kuang Tseng
    • 2
    • 3
    • 4
  • Pei-Lun Sun
    • 1
    • 5
    Email author
  • Yu-Hung Wu
    • 1
  • Gon-Shen Chen
    • 6
  1. 1.Department of DermatologyMackay Memorial HospitalTaipeiTaiwan
  2. 2.Division of Infectious Disease, Department of Internal MedicineMackay Memorial HospitalTaipeiTaiwan
  3. 3.Institute of Clinical MedicineNational Yang-Ming UniversityTaipeiTaiwan
  4. 4.Department of MedicineMackay Medical CollegeNew TaipeiTaiwan
  5. 5.Institute of Ecology and Evolutionary BiologyNational Taiwan UniversityTaipeiTaiwan
  6. 6.Division of Hematology, Department of Internal MedicineMackay Memorial HospitalTaipeiTaiwan

Personalised recommendations